We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUXAW
3826
CALL
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
– –
-176,394
Closed -$1.77M
PAQC
3827
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
– –
-1,092,762
Closed -$10.9M
PAQCW
3828
CALL
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
– –
-198,840
Closed -$1.99M
PIPP
3829
DELISTED
Pine Island Acquisition Corp.
PIPP
– –
-857,436
Closed -$8.56M
TEKK
3830
DELISTED
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
– –
-1,050,000
Closed -$10.5M
TWTR
3831
DELISTED
Twitter, Inc.
TWTR
– –
-1,444,730
Closed -$63.3M
BOAS
3832
DELISTED
BOA Acquisition Corp.
BOAS
– –
-1,119,480
Closed -$11.1M
BLSA
3833
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
– –
-50,000
Closed -$501K
ACII.WS
3834
CALL
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
– –
-431,000
Closed -$4.31M
BOAS.WS
3835
CALL
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
– –
-369,694
Closed -$3.67M
MACC.WS
3836
CALL
DELISTED
Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
MACC.WS
– –
-511,231
Closed -$5.02M
ENPC.WS
3837
CALL
DELISTED
Executive Network Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
ENPC.WS
– –
-450,000
Closed -$4.49M
ENPC
3838
DELISTED
Executive Network Partnering Corporation
ENPC
– –
-1,070,993
Closed -$10.7M
TMAC.WS
3839
CALL
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
– –
-411,122
Closed -$4.13M
LFTR
3840
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
– –
-804,291
Closed -$8.04M
HIGA
3841
DELISTED
H.I.G. Acquisition Corp.
HIGA
– –
-1,554,650
Closed -$15.6M
SANB
3842
DELISTED
Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
– –
-628,774
Closed -$6.37M
CCXI
3843
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-30,900
Closed -$1.59M
AVLR
3844
DELISTED
Avalara, Inc.
AVLR
– –
-116,969
Closed -$10.7M
Y
3845
DELISTED
Alleghany Corp
Y
– –
-8,565
Closed -$7.19M
GETY.WS
3846
CALL
DELISTED
Getty Images Holdings, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
GETY.WS
– –
-299,998
Closed -$2.04M
PING
3847
DELISTED
Ping Identity Holding Corp.
PING
– –
-80,527
Closed -$2.26M
SBII.WS
3848
CALL
DELISTED
Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
SBII.WS
– –
-394,048
Closed -$3.96M
GSQD.WS
3849
CALL
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
– –
-330,000
Closed -$3.28M
HTAQ.WS
3850
CALL
DELISTED
Hunt Companies Acquisition Corp. I Warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 per share
HTAQ.WS
– –
-49,999
Closed -$507K
152 153
154
155 156

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.